It seems that a decreased ubiquitin level can reduce the activation threshold of cells to environmental stressors, and UBC has been thus proposed as one promising candidate biomarker together with calmodulin-like protein 5 for the identification of newborns predisposed to develop atopic eczema (Holm et al., 2014). The gene discussed is CALML5; the disease is atopic eczema.